These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19068275)

  • 1. Cancer clinical trial outcomes: any progress in tumour-size assessment?
    Verweij J; Therasse P; Eisenhauer E;
    Eur J Cancer; 2009 Jan; 45(2):225-7. PubMed ID: 19068275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
    Ohorodnyk P; Eisenhauer EA; Booth CM
    Eur J Cancer; 2009 Sep; 45(13):2249-52. PubMed ID: 19545996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials.
    Lewis RM; Gordon DJ; Poole-Wilson PA; Borer JS; Zannad F
    Cardiology; 2008; 110(2):73-80. PubMed ID: 17975310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological surrogate end-points in cancer trials: potential uses, benefits and pitfalls.
    Cooper R; Kaanders JH
    Eur J Cancer; 2005 Jun; 41(9):1261-6. PubMed ID: 15939261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature.
    Armstrong AJ; Febbo PG
    Oncologist; 2009 Aug; 14(8):816-27. PubMed ID: 19684076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring response to therapy in rheumatoid arthritis - perspectives from the clinic.
    Daul P; Grisanti J
    Bull NYU Hosp Jt Dis; 2009; 67(2):236-42. PubMed ID: 19583560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patient data analysis to assess modifications to the RECIST criteria.
    Bogaerts J; Ford R; Sargent D; Schwartz LH; Rubinstein L; Lacombe D; Eisenhauer E; Verweij J; Therasse P;
    Eur J Cancer; 2009 Jan; 45(2):248-60. PubMed ID: 19095437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New guidelines for evaluating the therapeutic response of solid tumors: try them!].
    Négrier S
    Bull Cancer; 2000 Dec; 87(12):869-70. PubMed ID: 11174114
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Harmonization Project for response criteria in lymphoma clinical trials.
    Cheson BD
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):841-54. PubMed ID: 17908623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.
    Chiappa A; Makuuchi M; Lygidakis NJ; Zbar AP; Chong G; Bertani E; Sitzler PJ; Biffi R; Pace U; Bianchi PP; Contino G; Misitano P; Orsi F; Travaini L; Trifirò G; Zampino MG; Fazio N; Goldhirsch A; Andreoni B
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):65-75. PubMed ID: 19147371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging to select cancer therapy and evaluate treatment response.
    Mankoff DA
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):181-92. PubMed ID: 19293766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction?
    Beuth J
    Integr Cancer Ther; 2008 Dec; 7(4):311-6. PubMed ID: 19116226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value judgements that matter to patients remain implicit in oncology guidelines: an observational study.
    de Kort SJ; Burgers JS; Willems DL
    Neth J Med; 2009 Feb; 67(2):62-8. PubMed ID: 19299848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.